NCT06657040

Brief Summary

Intensive care units (ICUs) are environments specialized in the care of critically ill patients. Despite significant advances, ICUs are often seen as a dehumanized environment. Among the various stressors in ICUs, anxiety, pain, psychomotor agitation and mental confusion, need for mechanical restraint, lack of privacy, noise, restricted visiting time with family members and excessive lighting stand out. The tripod composed of pain, anxiety and delirium (often associated with the presence of psychomotor agitation, mental confusion and altered level of consciousness) has a high incidence and morbidity. A set of prevention, intensity reduction and treatment measures has been proposed for these conditions, with a growing number of scientific evidence supporting their routine use. Elderly patients tend to be particularly susceptible to the stressors described above. This aspect represents an additional source of concern for ICUs, since the elderly today represent the majority of patients admitted to ICUs. Hospitalization in ICUs after surgical procedures is often an unknown moment for the individual and, consequently, associated with the development of numerous unpleasant sensations, directly interfering with the patient's recovery. Music as a therapy tool in medical practice has been used since 1890. After a little more than two decades, in 1914 it was applied in a surgical procedure by physician Evan Kane as a way of "calming patients and diverting attention from fear". associated with combined therapy with local anesthesia. In this context, being a low-cost tool, with minimal adverse effects and high acceptability, the use of music has proven to be a great ally in the arsenal of non-pharmacological therapies for the prevention of delirium, anxiety and pain. We intend, through a randomized multicenter clinical trial, to investigate whether the use of music as therapy is capable of reducing the incidence of anxiety, pain and delirium in elderly patients undergoing surgical procedures and hospitalized during the postoperative period in intensive care units.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
360

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 24, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

October 24, 2024

Status Verified

July 1, 2024

Enrollment Period

Same day

First QC Date

September 11, 2024

Last Update Submit

October 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • combined frequency of delirium and anxiety

    The primary endpoint is the combined frequency of delirium and anxiety during the first 7 days of ICU stay Assessments will be performed using the form developed for the study, consisting of the CAM-ICU 7, the numeric pain scale (NRS) and the HADS-A scale. Additionally, the form will document the vital signs: systolic blood pressure, diastolic blood pressure and heart rate measured immediately before and after the intervention in the two periods of the day, in addition to data referring to the presence of pain and episodes of psychomotor agitation and/or delirium, as well as the use of analgesics and opioids in the period referring to the 12 hours prior to the application of the intervention. The CAM-ICU7 and NRS tools will be applied twice a day before and after the intervention, as well as the measurement of vital signs, while the HADS-A scale will be applied only once a day in the morning assessment.

    SEVEN DAYS

Study Arms (2)

INTERVENTION

ACTIVE COMPARATOR

The intervention group will receive a soundtrack through individual choice of anti-noise headphones. The music offer platform will be provided by an application developed by MusicCare (www.music.care/en/index.html) in two periods of the day (09:00 and 16:00), lasting 45 minutes each, for up to seven postoperative days or until discharge from the unit (whichever occurs first).

Other: MUSIC

STANDARD TREATMENT

PLACEBO COMPARATOR

IN THIS ARM, PATIENTS WILL UNDERGO STANDARD TREATMENT IN THE ICU WHERE THEY ARE ADMITTED AND FOR 45 MINUTES, TWICE A DAY, NOISE-CANCELLING HEADPHONES WILL BE USED WITHOUT PLAYING MUSIC.

Other: MUSIC

Interventions

MUSICOTHER

The intervention group will receive a soundtrack through individual choice of anti-noise headphones. The music offer platform will be provided by an application developed by MusicCare (www.music.care/en/index.html) in two periods of the day (09:00 and 16:00), lasting 45 minutes each, for up to seven postoperative days or until discharge from the unit (whichever occurs first). MusicCare has been widely tested in several countries and there are a large number of publications in anesthesiology, ICU, cardiology and neurology, among other specialties, demonstrating its safety and efficacy69,70. Patients who were hospitalized for more than 48 hours, that is, who received a minimum of 4 intervention periods, will be considered as patients with effective intervention. Patients with less time will be evaluated in the form of intention to treat.

INTERVENTIONSTANDARD TREATMENT

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Elective surgery admitted to the ICU in the immediate period after the surgical procedure; · Age equal to or greater than 65 years

You may not qualify if:

  • · Moderate to severe dementia, defined by 2 to 3 points in the clinical dementia rating (CDR)66;
  • Impossibility of verbal communication (eg: aphasia);
  • Lack of understanding of the Portuguese language;
  • Inability to listen to music due to hearing impairment or intolerance to the use of headphones;
  • Mechanical ventilation for more than 12 hours;
  • Richmond Agitation Sedation Scale (RASS) less than or equal to 324;
  • Neurosurgical and craniofacial procedures;
  • Refusal or failure to sign the free and informed consent form (TCLE).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Delirium

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 11, 2024

First Posted

October 24, 2024

Study Start

November 1, 2024

Primary Completion

November 1, 2024

Study Completion

January 1, 2025

Last Updated

October 24, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share